The number of regulatory T cells in transbronchial lung allograft biopsies is related to FoxP3 mRNA levels in bronchoalveolar lavage fluid and to the degree of acute cellular rejection

Transplant Immunology

Volumn 29, Issue 1-4, 2013, Pages 71-75

  Krustrup, Dorrit ^a   Madsen, Caroline B ^a   Iversen, Martin ^a   Engelholm, Lars ^b   Ryder, Lars P ^a   Andersen, Claus B ^a  

^a Rigshospitalet   (Denmark)

^b FINSEN LABORATORY   (Denmark)

Author keywords

Allograft rejection; FoxP3; Lung transplantation; Regulatory T cell

Indexed keywords

GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; TRANSCRIPTION FACTOR FOXP3;

ACUTE GRAFT REJECTION; ADULT; ALLOGRAFT; ARTICLE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; COMPARATIVE STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; LUNG LAVAGE; LUNG PARENCHYMA; LYMPHOCYTE COUNT; MALE; MIDDLE AGED; NON INVASIVE MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSBRONCHIAL BIOPSY; YOUNG ADULT;

ALLOGRAFT REJECTION; FOXP3; LUNG TRANSPLANTATION; REGULATORY T CELL;

ADULT; ALLOGRAFTS; BRONCHOALVEOLAR LAVAGE; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; HUMANS; IMMUNITY, CELLULAR; LUNG; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 84897064222     PISSN: 09663274     EISSN: 18785492     Source Type: Journal    
DOI: 10.1016/j.trim.2013.08.002     Document Type: Article

References (30)

1. Burton C.M., Milman N., Carlsen J., Arendrup H., Eliasen K., Andersen C.B., et al. The Copenhagen National Lung Transplant Group: survival after single lung, double lung, and heart-lung transplantation. J Heart Lung Transplant Nov. 2005, 24(11):1834-1843.
2. Christie J.D., Edwards L.B., Kucheryavaya A.Y., Benden C., Dipchand A.I., Dobbels F., et al. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant Oct. 2012, 31(10):1073-1086.
3. Estenne M., Hertz M.I. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med Aug. 15 2002, 166(4):440-444.
4. Stewart S., Fishbein M.C., Snell G.I., Berry G.J., Boehler A., Burke M.M., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant Dec. 2007, 26(12):1229-1242.
5. Burton C.M., Iversen M., Carlsen J., Mortensen J., Andersen C.B., Steinbruchel D., et al. Acute cellular rejection is a risk factor for bronchiolitis obliterans syndrome independent of post-transplant baseline FEV1. J Heart Lung Transplant Sep. 2009, 28(9):888-893.
6. Maloy K.J., Powrie F. Regulatory T cells in the control of immune pathology. Nat Immunol Sep. 2001, 2(9):816-822.
7. Sakaguchi S., Sakaguchi N., Shimizu J., Yamazaki S., Sakihama T., Itoh M., et al. Immunologic tolerance maintained by CD25+CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev Aug. 2001, 182:18-32.
8. Shevach E.M. CD4+CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol Jun. 2002, 2(6):389-400.
9. Wood K.J., Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol Mar. 2003, 3(3):199-210.
10. Chauhan S.K., Saban D.R., Lee H.K., Dana R. Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation. J Immunol Jan. 1 2009, 182(1):148-153.
11. Boros P., Bromberg J.S. Human FOXP3+ regulatory T cells in transplantation. Am J Transplant Aug. 2009, 9(8):1719-1724.
12. Chenivesse C., Chang Y., Azzaoui I., Ait Y.S., Morales O., Ple C., et al. Pulmonary CCL18 recruits human regulatory T cells. J Immunol Jul. 1 2012, 189(1):128-137.
13. Li X.C., Turka L.A. An update on regulatory T cells in transplant tolerance and rejection. Nat Rev Nephrol Oct. 2010, 6(10):577-583.
14. Fontenot J.D., Gavin M.A., Rudensky A.Y. Foxp3 programs the development and function of CD4+CD25+ regulatory T cells. Nat Immunol Apr. 2003, 4(4):330-336.
15. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol Apr. 2007, 19(4):345-354.
16. Madsen C.B., Norgaard A., Iversen M., Ryder L.P. Elevated mRNA levels of CTLA-4, FoxP3, and granzyme B in BAL, but not in blood, during acute rejection of lung allografts. Transpl Immunol Oct. 2010, 24(1):26-32.
17. Bhorade S.M., Chen H., Molinero L., Liao C., Garrity E.R., Vigneswaran W.T., et al. Decreased percentage of CD4+FoxP3+ cells in bronchoalveolar lavage from lung transplant recipients correlates with development of bronchiolitis obliterans syndrome. Transplantation Sep. 15 2010, 90(5):540-546.
18. Gregson A.L., Hoji A., Saggar R., Ross D.J., Kubak B.M., Jamieson B.D., et al. Bronchoalveolar immunologic profile of acute human lung transplant allograft rejection. Transplantation Apr. 15 2008, 85(7):1056-1059.
19. Meloni F., Morosini M., Solari N., Bini F., Vitulo P., Arbustini E., et al. Peripheral CD4+CD25+ Treg cell expansion in lung transplant recipients is not affected by calcineurin inhibitors. Int Immunopharmacol Dec. 20 2006, 6(13-14):2002-2010.
20. Warnecke G., Avsar M., Morancho M., Peters C., Thissen S., Kruse B., et al. Preoperative low-dose irradiation promotes long-term allograft acceptance and induces regulatory T cells in a porcine model of pulmonary transplantation. Transplantation Jul. 15 2006, 82(1):93-101.
21. Nakagiri T., Warnecke G., Avsar M., Thissen S., Kruse B., Kuhn C., et al. Lung function early after lung transplantation is correlated with the frequency of regulatory T cells. Surg Today Feb. 2012, 42(3):250-258.
22. Neujahr D.C., Cardona A.C., Ulukpo O., Rigby M., Pelaez A., Ramirez A., et al. Dynamics of human regulatory T cells in lung lavages of lung transplant recipients. Transplantation Aug. 27 2009, 88(4):521-527.
23. Dijke I.E., Caliskan K., Korevaar S.S., Maat A.P., Zondervan P.E., Balk A.H., et al. FOXP3 mRNA expression analysis in the peripheral blood and allograft of heart transplant patients. Transpl Immunol Jan 2008, 18(3):250-254.
24. Stewart S., Fishbein M.C., Snell G.I., Berry G.J., Boehler A., Burke M.M., et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant Dec 2007, 26(12):1229-1242.
25. Madsen C.B., Norgaard A., Iversen M., Ryder L.P. Elevated mRNA levels of CTLA-4, FoxP3, and granzyme B in BAL, but not in blood, during acute rejection of lung allografts. Transpl Immunol Oct. 2010, 24(1):26-32.
26. Vogel C., Marcotte E.M. Insights into the regulation of protein abundance from proteomic and transcriptomic analyses. Nat Rev Genet Apr. 2012, 13(4):227-232.
27. Guo Y., Xiao P., Lei S., Deng F., Xiao G.G., Liu Y., et al. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) May 2008, 40(5):426-436.
28. Kollins D., Stoelcker B., Hoffmann U., Bergler T., Reinhold S., Banas M.C., et al. FOXP3+ regulatory T-cells in renal allografts: correlation with long-term graft function and acute rejection. Clin Nephrol Feb. 2011, 75(2):91-100.
29. Batsford S., Dickenmann M., Durmuller U., Hopfer H., Gudat F., Mihatsch M. Is monitoring of FOXP3 Treg cells in renal transplants during acute cellular rejection episodes useful?. Clin Nephrol Feb. 2011, 75(2):101-106.
30. Burton C.M., Iversen M., Scheike T., Carlsen J., Andersen C.B. Minimal acute cellular rejection remains prevalent up to 2years after lung transplantation: a retrospective analysis of 2697 transbronchial biopsies. Transplantation Feb. 27 2008, 85(4):547-553.